Home › Kidney Diseases › California › San Francisco
Kidney Diseases clinical trials in San Francisco, CA
4 studies for Kidney Diseases are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
RecruitingObservational study
- University of California San Francisco, San Francisco
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
RecruitingPhase 1/2
- University of California - San Francisco, San Francisco
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
RecruitingPhase 3
- Kaiser Permanente San Francisco Medical Center, San Francisco
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RecruitingPhase 3
- University of California, San Francisco School of Medicine, San Francisco
About Kidney Diseases
Properly functioning kidneys are critical for maintaining good health. Diabetes, high blood pressure, or family history can increase risk of kidney disease.
More about Kidney Diseases on MedlinePlus
Kidney Diseases trials in other cities
- Atlanta, GA11 studies
- Houston, TX8 studies
- Orlando, FL7 studies
- Miami, FL6 studies
- Philadelphia, PA5 studies
- Dallas, TX5 studies
- Boston, MA5 studies
- Durham, NC5 studies
- New York City, NY5 studies
- Denver, CO5 studies
- Winston-Salem, NC4 studies
- Los Angeles, CA4 studies
Other studies in San Francisco
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Non-Small Cell Lung Cancer37 studies
- Heart Failure29 studies
- Metastatic Cancer25 studies
- Lung Cancer23 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Cardiovascular Disease20 studies
- Pancreatic Cancer19 studies
- Glioblastoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.